<p>Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management</p>-Reference-Cited by-同舟云学术

Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management

Published:2020-09 Issue: Volume:Volume 16 Page:353-365
ISSN:1178-2048
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:VHRM

Author:

Yehualashet Awgichew Shewasinad^ORCID,Belachew Teshome Fentik^ORCID,Kifle Zemene Demelash^ORCID,Abebe Ayele Mamo^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference73 articles.

1. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

2. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: a nation-wide, cross-sectional survey

3. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015

4. Reappraisal of Ischemic Heart Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic inhibition of mitochondrial fatty acid β-oxidation impedes zebrafish ventricle regeneration;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Effect of Simultaneous Lower- and Upper-Body Ischemic Preconditioning on Lactate, Heart Rate, and Rowing Performance in Healthy Males and Females;Applied Sciences;2024-04-23

3. Unravelling the Interplay between Cardiac Metabolism and Heart Regeneration;International Journal of Molecular Sciences;2023-06-18

4. Aquaporins: Important players in the cardiovascular pathophysiology;Pharmacological Research;2022-09

5. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation;Pharmaceutics;2022-06-21